Is the promise of randomized control trials ("evidence-based medicine") overstated?
- 1 February 2002
- journal article
- research article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 2 (1) , 1-8
- https://doi.org/10.1007/s11910-002-0044-z
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Supplement to the Guidelines for the Management of Transient Ischemic AttacksStroke, 1999
- Guidelines for Carotid EndarterectomyStroke, 1998
- Antiplatelet Therapy in Secondary Prevention of StrokeCNS Drugs, 1997
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials.Stroke, 1988
- Failure of Extracranial–Intracranial Arterial Bypass to Reduce the Risk of Ischemic StrokeNew England Journal of Medicine, 1985
- Are terms such as completed stroke or RIND of continued usefulness?Stroke, 1983
- A randomized trial of aspirin and sulfinpyrazone in patients with TIA.Stroke, 1982
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- Controlled trial of aspirin in cerebral ischemia.Stroke, 1977